Financial Instruments |
Financial Instruments Cash Equivalents and Available-for-Sale Debt Investments Cash equivalents and available-for-sale debt investments were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of July 31, 2020 | | | | | | | | As of October 31, 2019 | | | | | | | | Cost | | Gross Unrealized Gain | | | | Fair Value | | Cost | | Gross Unrealized Gain | | | | Fair Value | | In millions | | | | | | | | | | | | | | | Cash Equivalents: | | | | | | | | | | | | | | | | Time deposits | $ | 4,778 | | | $ | — | | | | | $ | 4,778 | | | $ | 803 | | | $ | — | | | | | $ | 803 | | Money market funds | 1,668 | | | — | | | | | 1,668 | | | 859 | | | — | | | | | 859 | | Total cash equivalents | 6,446 | | | — | | | | | 6,446 | | | 1,662 | | | — | | | | | 1,662 | | Available-for-Sale Debt Investments: | | | | | | | | | | | | | | | | Foreign bonds | 83 | | | 14 | | | | | 97 | | | 110 | | | 23 | | | | | 133 | | Other debt securities | 20 | | | 1 | | | | | 21 | | | 32 | | | — | | | | | 32 | | Total available-for-sale debt investments | 103 | | | 15 | | | | | 118 | | | 142 | | | 23 | | | | | 165 | | Total cash equivalents and available-for-sale debt investments | $ | 6,549 | | | $ | 15 | | | | | $ | 6,564 | | | $ | 1,804 | | | $ | 23 | | | | | $ | 1,827 | |
As of July 31, 2020 and October 31, 2019, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. Time deposits were primarily issued by institutions in the U.S. as of July 31, 2020 and outside the U.S. as of October 31, 2019. The estimated fair value of the available-for-sale debt investments may not be representative of values that will be realized in the future. Contractual maturities of available-for-sale debt investments were as follows: | | | | | | | | | | | | | July 31, 2020 | | | | Amortized Cost | | Fair Value | | In millions | | | | | | | Due in more than five years | $ | 103 | | | $ | 118 | | | $ | 103 | | | $ | 118 | |
Equity securities investments in privately held companies are included in Long-term financing receivables and other assets in the Condensed Consolidated Balance Sheets. The carrying amount of those without readily determinable fair values amounted to $283 million and $190 million at July 31, 2020 and October 31, 2019, respectively. The carrying amount of those marketable equity securities with readily determinable fair value amounted to $29 million as of July 31, 2020. The Company did not have any marketable equity securities with readily determinable fair value as of October 31, 2019. Investments in equity securities that are accounted for using the equity method are included in Investments in equity interests in the Condensed Consolidated Balance Sheets. These amounted to $2.3 billion at July 31, 2020 and October 31, 2019. The Company did not recognize any impairments on these equity investments during the nine months ended July 31, 2020. Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets The gross notional and fair value of derivative instruments in the Condensed Consolidated Balance Sheets were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of July 31, 2020 | | | | | | | | | | As of October 31, 2019 | | | | | | | | | | | | Fair Value | | | | | | | | | | Fair Value | | | | | | | | Outstanding Gross Notional | | Other Current Assets | | Long-Term Financing Receivables and Other Assets | | Other Accrued Liabilities | | Long-Term Other Liabilities | | Outstanding Gross Notional | | Other Current Assets | | Long-Term Financing Receivables and Other Assets | | Other Accrued Liabilities | | Long-Term Other Liabilities | | In millions | | | | | | | | | | | | | | | | | | | Derivatives designated as hedging instruments | | | | | | | | | | | | | | | | | | | | Fair value hedges: | | | | | | | | | | | | | | | | | | | | Interest rate contracts | $ | 6,850 | | | $ | 4 | | | $ | 255 | | | $ | — | | | $ | — | | | $ | 6,850 | | | $ | — | | | $ | 72 | | | $ | 11 | | | $ | — | | Cash flow hedges: | | | | | | | | | | | | | | | | | | | | Foreign currency contracts | 7,929 | | | 61 | | | 85 | | | 176 | | | 47 | | | 8,578 | | | 164 | | | 141 | | | 45 | | | 27 | | Interest rate contracts | 500 | | | — | | | — | | | 4 | | | — | | | 500 | | | — | | | 1 | | | — | | | — | | Net investment hedges: | | | | | | | | | | | | | | | | | | | | Foreign currency contracts | 1,778 | | | 29 | | | 37 | | | 13 | | | 6 | | | 1,766 | | | 31 | | | 36 | | | 18 | | | 10 | | Total derivatives designated as hedging instruments | 17,057 | | | 94 | | | 377 | | | 193 | | | 53 | | | 17,694 | | | 195 | | | 250 | | | 74 | | | 37 | | Derivatives not designated as hedging instruments | | | | | | | | | | | | | | | | | | | | Foreign currency contracts | 6,013 | | | 86 | | | 7 | | | 65 | | | 1 | | | 6,398 | | | 17 | | | 3 | | | 33 | | | 3 | | Other derivatives | 101 | | | 2 | | | — | | | — | | | — | | | 97 | | | 3 | | | — | | | — | | | — | | Total derivatives not designated as hedging instruments | 6,114 | | | 88 | | | 7 | | | 65 | | | 1 | | | 6,495 | | | 20 | | | 3 | | | 33 | | | 3 | | Total derivatives | $ | 23,171 | | | $ | 182 | | | $ | 384 | | | $ | 258 | | | $ | 54 | | | $ | 24,189 | | | $ | 215 | | | $ | 253 | | | $ | 107 | | | $ | 40 | |
Offsetting of Derivative Instruments The Company recognizes all derivative instruments on a gross basis in the Condensed Consolidated Balance Sheets. The Company's derivative instruments are subject to master netting arrangements and collateral security arrangements. The Company does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under collateral security agreements. The information related to the potential effect of the Company's use of the master netting agreements and collateral security agreements were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of July 31, 2020 | | | | | | | | | | | | | In the Condensed Consolidated Balance Sheets | | | | | | | | | | | | | (i) | | (ii) | | (iii) = (i)–(ii) | | (iv) | | (v) | | | (vi) = (iii)–(iv)–(v) | | | | | | | | Gross Amounts Not Offset | | | | | | | Gross Amount Recognized | | Gross Amount Offset | | Net Amount Presented | | Derivatives | | Financial Collateral | | | Net Amount | | In millions | | | | | | | | | | | | Derivative assets | $ | 566 | | | $ | — | | | $ | 566 | | | $ | 202 | | | $ | 391 | | (1) | | $ | (27) | | Derivative liabilities | $ | 312 | | | $ | — | | | $ | 312 | | | $ | 202 | | | $ | 83 | | (2) | | $ | 27 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of October 31, 2019 | | | | | | | | | | | | | In the Condensed Consolidated Balance Sheets | | | | | | | | | | | | | (i) | | (ii) | | (iii) = (i)–(ii) | | (iv) | | (v) | | | (vi) = (iii)–(iv)–(v) | | | | | | | | Gross Amounts Not Offset | | | | | | | Gross Amount Recognized | | Gross Amount Offset | | Net Amount Presented | | Derivatives | | Financial Collateral | | | Net Amount | | In millions | | | | | | | | | | | | Derivative assets | $ | 468 | | | $ | — | | | $ | 468 | | | $ | 123 | | | $ | 263 | | (1) | | $ | 82 | | Derivative liabilities | $ | 147 | | | $ | — | | | $ | 147 | | | $ | 123 | | | $ | 19 | | (2) | | $ | 5 | |
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for the Company's asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date. (2)Represents the collateral posted by the Company in cash or through the re-use of counterparty cash collateral as of the respective reporting date for the Company's liability position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date. As of July 31, 2020, $83 million of collateral posted was entirely through re-use of counterparty collateral. As of October 31, 2019, $19 million of collateral posted was entirely by way of re-use of counterparty collateral. The amounts recorded on the Condensed Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Carrying amount of the hedged assets/ (liabilities) | | | | Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets/ (liabilities) | | | | As of | | | | As of | | | | July 31, 2020 | | October 31, 2019 | | July 31, 2020 | | October 31, 2019 | | In millions | | | | In millions | | | Notes payable and short-term borrowings | $ | (3,004) | | | $ | (2,987) | | | $ | (4) | | | $ | 11 | | Long-term debt | $ | (4,093) | | | $ | (3,908) | | | $ | (255) | | | $ | (72) | |
The pre-tax effect of derivative instruments in cash flow and net investment hedging relationships recognized in Other Comprehensive Income ("OCI") were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Gains (Losses) Recognized in OCI on Derivatives | | | | | | | | Three months ended July 31, 2020 | | Three months ended July 31, 2019 | | Nine months ended July 31, 2020 | | Nine months ended July 31, 2019 | | In millions | | | | | | | Derivatives in Cash Flow Hedging relationship | | | | | | | | Foreign exchange contracts | $ | (456) | | | $ | 63 | | | $ | (79) | | | $ | 225 | | Interest rate contracts | — | | | — | | | (6) | | | — | | Derivatives in Net Investment Hedging relationship | | | | | | | | Foreign exchange contracts | (83) | | | (18) | | | 50 | | (23) | | Total | $ | (539) | | | $ | 45 | | | $ | (35) | | | $ | 202 | |
As of July 31, 2020, the Company expects to reclassify an estimated net accumulated other comprehensive loss of approximately $99 million, net of taxes, to earnings in the next twelve months along with the earnings effects of the related forecasted transactions associated with cash flow hedges. Effect of Derivative Instruments on the Condensed Consolidated Statements of Earnings The pre-tax effect of derivative instruments on the Condensed Consolidated Statements of Earnings were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gains (Losses) Recognized in Income | | | | | | | | | | | | | | | | Three months ended July 31, 2020 | | | | Three months ended July 31, 2019 | | | | Nine months ended July 31, 2020 | | | | Nine months ended July 31, 2019 | | | | Net revenue | | Interest and other, net | | Net revenue | | Interest and other, net | | Net revenue | | Interest and other, net | | Net revenue | | Interest and other, net | | In millions | | | | | | | | | | | | | | | Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value hedges, cash flow hedges and derivatives not designated as hedging instruments are recorded | $ | 6,816 | | | $ | (71) | | | $ | 7,217 | | | $ | (70) | | | $ | 19,774 | | | $ | (158) | | | $ | 21,920 | | | $ | (139) | | Gains (losses) on derivatives in fair value hedging relationships | | | | | | | | | | | | | | | | Interest rate contracts | | | | | | | | | | | | | | | | Hedged items | $ | — | | | $ | (13) | | | $ | — | | | $ | (123) | | | $ | — | | | $ | (198) | | | $ | — | | | $ | (341) | | Derivatives designated as hedging instruments | — | | | 13 | | | — | | | 123 | | | — | | | 198 | | | — | | | 341 | | Gains (losses) on derivatives in cash flow hedging relationships | | | | | | | | | | | | | | | | Foreign exchange contracts | | | | | | | | | | | | | | | | Amount of gains (losses) reclassified from accumulated other comprehensive income into income | 23 | | | (264) | | | 42 | | | 16 | | | 97 | | | (55) | | | 168 | | | 91 | | Interest rate contracts | | | | | | | | | | | | | | | | Amount of gains (losses) reclassified from accumulated other comprehensive income into income | — | | | (1) | | | — | | | — | | | — | | | (1) | | | — | | | — | | Gains (losses) on derivatives not designated as hedging instruments | | | | | | | | | | | | | | | | Foreign exchange contracts | — | | | 8 | | | — | | | 55 | | | — | | | 53 | | | — | | | (68) | | Other derivatives | — | | | (6) | | | — | | | (2) | | | — | | | (1) | | | — | | | 5 | | Total gains (losses) | $ | 23 | | | $ | (263) | | | $ | 42 | | | $ | 69 | | | $ | 97 | | | $ | (4) | | | $ | 168 | | | $ | 28 | |
|